Pfizer urges US to allow COVID booster jabs for all adults Coronavirus pandemic News

FDA advisors ruled out Pfizer boosters for everyone in September, saying they didn’t think healthy adults needed an extra dose.

Pharmaceutical giant Pfizer has applied for permission from U.S. health regulators promoter COVID-19 vaccine outbreaks for everyone over the age of 18 are among the concerns that coronavirus infections could re-grow in the U.S. in the coming winter months.

Older Americans and those who are more vulnerable to infections are already eligible for a third booster jab in the U.S.

On Tuesday, Pfizer-BioNTech asked the U.S. Food and Drug Administration (FDA) to select all adults in the country.

The demand comes amid concerns that COVID-19 infections could rise again, as the holiday season and cold weather bring more people inside for large gatherings of friends and family.

According to the U.S. Centers for Disease Control and Prevention (CDC), new coronavirus infections, hospitalizations, and deaths have declined in recent weeks across the country. But a large portion of the U.S. population remains unaccounted for.

CDCs final figures show that 70 percent of U.S. adults are fully vaccinated and about 21.5 million booster doses have been given to people who are fully vaccinated. The US also recently approved the Pfizer vaccine kids between the years five and 11.

The administration of President Joe Biden was initially planned promoters for all adults but in September it had a rough setback when FDA scientific advisors ruled out additional doses of Pfizer for everyone.

The panel did not believe that young and healthy people needed another dose, especially when the majority of the world’s population it remains unvaccinated.

Pfizer said it is sending the results of a promotional study to 10,000 people to indicate that it is time to expand its promotional campaign in the US.

The study concluded that a promoter can restore almost 96 percent protection against symptomatic infection, even if it is contagious. Delta variant it was rising. The side effects were similar to those seen with the company’s first two shots.

The U.S. has authorized three vaccines and boosters in the U.S.: Pfizer-BioNTech, Moderna, and Johnson & Johnson.

Pfizer says it is sending the results of a promotional study to 10,000 people to indicate that it is time to expand its promotional campaign in the US. [Emily Elconin/Reuters]

Under current rules, people who initially received Pfizer or Moderna jabs are eligible to receive a booster six months later if they are 65 or older, or are at high risk of contracting COVID-19 because of basic health problems or their working or living conditions.

Since Johnson & Johnson’s single-dose vaccines have not been as effective as their two-dose competitors, any Johnson & Johnson vaccine can get a booster at least two months later.

Under this policy, two out of three adults vaccinated are expected to be vaccinated in the coming months.

The United States has also allowed people to take a boost from another company’s vaccine, which is often said. “mixing and matching“.

If the FDA allows Pfizer boosters for all adults, the CDC will provide recommendations on how to use them.